F13.15
Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.15 refers to a condition where an individual misuses sedative, hypnotic, or anxiolytic medications, leading to a psychotic disorder induced by these substances. These medications are often prescribed to help with anxiety, sleep issues, or to relax, but misuse can result in serious mental health complications. Recognizing and understanding this condition can help promote awareness and encourage proper medical management.
Causes & Symptoms
Clinical Causes: Prolonged or excessive use of sedatives, hypnotics, or anxiolytics Misuse of prescription medications outside of recommended dosages Dependence on these medications to manage mental health or stress Co-occurring mental health conditions such as anxiety or depression leading to misuse Lack of proper medical supervision during medication use
Key Symptoms: Hallucinations (seeing or hearing things that are not present) Delusional thinking or false beliefs Severe confusion or disorientation Agitated behavior or restlessness Mood swings or emotional instability Sleep disturbances or insomnia Paranoia or mistrust of others Physical signs such as drowsiness, slurred speech, or unsteady movements
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical evaluation including a detailed medical history and physical examination. Healthcare providers may perform mental status assessments, inquire about medication use, and evaluate for signs of intoxication or withdrawal. Laboratory tests might be used to detect the presence of sedatives or hypnotics in the system. Mental health assessments are essential to identify co-existing conditions or substance dependence.
Treatment Protocols: Treatment typically involves a combination of medical, psychological, and supportive interventions, including: - Medication management to safely detoxify from sedatives and address symptoms - Psychotherapy such as cognitive-behavioral therapy to explore underlying issues and develop coping strategies - Support groups or peer support programs - Monitoring and managing withdrawal symptoms under medical supervision - Long-term strategies to prevent relapse, including counseling and medication adherence The aim of treatment is to stabilize mental health, reduce substance misuse, and address the underlying causes contributing to the abuse.
Clinical Advice & FAQs
Billing Guidance
Is F13.15 a billable ICD-10 code?
Yes, F13.15 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.15?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
